Patents Assigned to Mythic Therapeutics, Inc.
  • Publication number: 20240158493
    Abstract: Provided herein are antigen-binding protein constructs and antibodies and uses of the same.
    Type: Application
    Filed: April 5, 2022
    Publication date: May 16, 2024
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Alexander J. Nichols, Brian P. Fiske, Nimish Gera
  • Publication number: 20240141065
    Abstract: Provided herein are antibodies and uses of the same.
    Type: Application
    Filed: February 3, 2022
    Publication date: May 2, 2024
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Brian P. Fiske, Nimish Gera, Alexander J. Nichols
  • Publication number: 20240101688
    Abstract: Provided herein are antibodies and uses of the same.
    Type: Application
    Filed: November 15, 2023
    Publication date: March 28, 2024
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Brian P. Fiske, Nimish Gera, Alexander J. Nichols
  • Publication number: 20220348679
    Abstract: Provided herein are antigen-binding protein constructs and uses of the same.
    Type: Application
    Filed: October 2, 2020
    Publication date: November 3, 2022
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Alexander J. Nichols, Brian Fiske, Nimish Gera
  • Publication number: 20220324969
    Abstract: Provided herein are antigen-binding protein constructs capable of specifically binding CD33 or an epitope of CD33 presented on the surface of a target mammalian cell, wherein said antigen binding is pH-dependent. Provided are also uses of said antigen-binding protein constructs.
    Type: Application
    Filed: June 5, 2020
    Publication date: October 13, 2022
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Alexander J. Nichols, Brian P. Fiske, Nimish Gera
  • Publication number: 20220313845
    Abstract: Provided herein are antigen-binding protein constructs capable of specifically binding DLL3 or an epitope of DLL3 presented on the surface of a target mammalian cell, wherein said antigen binding is pH-dependent. Provided are also uses of said antigen-binding protein constructs.
    Type: Application
    Filed: June 5, 2020
    Publication date: October 6, 2022
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Alexander J. Nichols, Brian P. Fiske, Nimish Gera
  • Publication number: 20220306751
    Abstract: Provided herein are antigen-binding protein constructs and uses of the same.
    Type: Application
    Filed: September 11, 2020
    Publication date: September 29, 2022
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Alexander J. Nichols, Brian P. Fiske, Nimish Gera
  • Publication number: 20220298260
    Abstract: Provided herein are antigen-binding protein constructs capable of specifically binding FOLR1 or an epitope of FOLR1 presented on the surface of a target mammalian cell, wherein said antigen binding is pH-dependent. Provided are also uses of said antigen-binding protein constructs.
    Type: Application
    Filed: June 5, 2020
    Publication date: September 22, 2022
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Alexander J. Nichols, Brian P. Fiske, Nimish Gera
  • Publication number: 20220288219
    Abstract: Provided herein are antigen-binding protein constructs capable of specifically binding CD22 or an epitope of CD22 presented on the surface of a target mammalian cell, wherein said antigen binding is pH-dependent. Provided are also uses of said antigen-binding protein constructs.
    Type: Application
    Filed: July 8, 2020
    Publication date: September 15, 2022
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Alexander J. Nichols, Brian P. Fiske, Nimish Gera
  • Publication number: 20220281984
    Abstract: Provided herein are antigen-binding protein constructs capable of specifically binding MET or an epitope of MET presented on surface of a target mammalian cell, wherein said antigen binding is pH-dependent. Provided are also uses of said antigen-binding protein constructs.
    Type: Application
    Filed: July 30, 2020
    Publication date: September 8, 2022
    Applicant: Mythic Therapeutics, Inc.
    Inventors: Alexander J. Nichols, Brian P. Fiske, Nimish Gera